Background-Silent brain infarcts (SBI) and white matter hyperintensities (WMH) are
Stroke prevalence in the adult population of the United States is estimated at 3.0%, with an average of one person every 4 minutes dying of a stroke. 1 The morbidity, mortality and economic burden associated with stroke is huge, making its prevention a public health priority.
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In population-based studies, the prevalence of asymptomatic vascular brain lesions is substantially higher than that of clinically overt disease. Silent brain infarcts (SBI) have been documented in 7% to 28% of subjects without prior stroke, with a steep increase in prevalence observed with aging. [2] [3] [4] [5] [6] [7] [8] Cerebral white matter hyperintensities (WMH) have also been described in asymptomatic people in the general population. [9] [10] [11] [12] SBI and WMH are associated with an increased risk of future clinical stroke, cognitive impairment, and dementia. 10, 11, [13] [14] [15] Left ventricular (LV) systolic function measured as ejection fraction (LVEF) is strongly associated with incident stroke and with cognitive impairment in the setting of congestive heart failure and coronary artery disease. 16, 17 The prevalence of SBI in patients with heart failure is higher compared to that observed in unselected populations. 18, 19 LV dysfunction has also been found more often in patients with stroke compared to stroke-free controls. 20 However, in the general population, and in the absence of heart disease, it is not known whether LV systolic function predicts subclinical brain disease. In a previous study, LVEF was not associated with WMH volume (WMHV) in the general population. 21 LV global longitudinal strain (GLS) is an echocardiographic measure of LV function that can unmask subclinical systolic abnormalities, even when LVEF is in the normal range, in a variety of conditions that are also potent risk factors for stroke, such as arterial hypertension and diabetes mellitus. In fact, GLS has prognostic value for cardiovascular events and mortality that is independent and additive to that of LVEF. 22, 23 It is not known whether GLS is associated with the presence of subclinical brain disease in subjects without heart disease. If demonstrated, this association might be of value in the Left ventricular (LV) systolic function measured as ejection fraction (LVE VE EF) F) F i is s st st stro ro rong ng n ly ly associated with incident stroke and with cognitive impairment in the setting of congestive heart fa ail ilur u ure e e an and d d co co orona na nar ry ry artery disease. 16, 17 The preva va v le e ence of SBI in n pa p p ti ien en ent ts ts with heart failure is h hi high h her e compare red d d t to o t tha ha h t t ob ob obse se ser rv ve ved d in in n u uns nse elec c cte e ed po o op p pula a ati ti ion ons s s. 18, 18, 1 19 19 19 L L LV V dy dy dys sf fun un nct ct ctio ion n ha ha has s s al al a so o o b be e een n n identification of cerebrovascular disease at an asymptomatic stage. Accordingly, the aim of the present study was to investigate the association of LV systolic function, measured by LVEF and GLS, with subclinical cerebrovascular disease in a community-based cohort without clinical stroke or overt cardiac disease.
Methods

Study population
The Cardiovascular Abnormalities and Brain Lesion (CABL) study is a community-based epidemiologic study designed to investigate the cardiovascular predictors of silent cerebrovascular disease in the community. CABL based its recruitment on the Northern
Manhattan Study (NOMAS), a population-based prospective study that enrolled 3, 298 participants from the community living in northern Manhattan between 1993 and 2001. The study design and recruitment details of NOMAS have been described previously. 24 Beginning in 2003, participants were invited to participate in an MRI substudy if they: 1) were at least 55 years of age; 2) had no contraindications to MRI; and 3) did not have a prior diagnosis of stroke.
From September 2005 to July 2010, NOMAS MRI participants that voluntarily agreed to undergo a more extensive cardiovascular evaluation including transthoracic echocardiography were included in CABL. Participants for whom echocardiography and brain MRI information were available constitute the sample of the present study. Participants with non-sinus rhythm at the time of the echocardiogram, history of atrial fibrillation or atrial flutter, significant mitral or aortic valve disease, and coronary artery disease were excluded from the present analysis.
Written informed consent was obtained from all study participants. 
Risk factors assessment
Cardiovascular risk factors were ascertained through direct examination and interview by trained research assistants. Systolic (SBP) and diastolic blood pressure (DBP) were measured at the nondominant arm in a sitting position after 5 minutes of rest, using a mercury sphygmomanometer and a proportioned arm cuff. Study participants were not asked to discontinue anti-hypertensive medications on the day of the visit. Two BP measurements were performed and averaged.
Hypertension was defined as SBP 140 mm Hg or DBP 90 mm Hg, or the participant's selfreported history of hypertension or use of anti-hypertensive medication. Diabetes mellitus (DM) was defined as fasting blood glucose 126 mg/dL or the participant's self-reported history of DM or use of diabetes medications. Hypercholesterolemia was defined as total serum cholesterol >240 mg/dL, a patient's self-report of hypercholesterolemia or use of lipid-lowering treatment.
Cigarette smoking, either at the time of the interview or in the past, was recorded. Coronary artery disease (CAD) was defined as a history of myocardial infarction, coronary artery bypass grafting, percutaneous coronary intervention, typical angina or use of anti-ischemic medications.
Atrial fibrillation was defined from ECG at the time of echocardiography or from self-reported history. The race-ethnicity classification was based on self-identification, and categorized as black, Hispanic and white.
Echocardiographic assessment
Two-dimensional echocardiography
Transthoracic echocardiography was performed using a commercially available system (iE 33, Philips, Andover, MA) by a trained, registered cardiac sonographer according to a standardized protocol. Interventricular septum and posterior wall thickness, LV end-diastolic diameter, and was defined as fasting blood glucose 126 mg/dL or the participant's self-reporte te ed d h hi h st st stor r ory y y of of of DM or use of diabetes medications. Hypercholesterolemia was defined as total serum cholesterol >2 240 40 40 m m mg/ g/ g/dL dL dL, a pa pa at ti tie ent's self-report of hyperchole le lest te erolemia or us se e e of f l l lip ip ipi id-lowering treatment.
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Speckle-tracking strain imaging
Speckle-tracking analysis was performed off-line using commercially available software (QLAB Advanced Quantification Software version 8.1, Philips) as previously described. 28 Briefly, speckle-tracking analysis of LV myocardial deformation over the longitudinal axis was performed from two-dimensional gray-scale loops by automatic tracking of myocardial speckles after manual selection of landmark points. Global longitudinal systolic strain (GLS) was calculated averaging the negative peak of longitudinal strain from 12 ventricular segments from the apical 4-chamber and 2-chamber views. At least two cardiac cycles were recorded at a frame perpendicular to the inflow jet at the level of mitral valve leaflet tips. The peak e ea a arly ly y v v vel el eloc oc ocit it ity y y E), late velocity (A), and deceleration time of the mitral inflow were measured, and the E/A a ati tio o o w wa was s ca ca calc lc lculat at ate ed ed. Mitral annular velocities we we were re evaluated by pu p p ls sed ed ed--w -wave tissue-Doppler m ma ag aging and sa sam mp mple led d d on on n t t the he he l l lo on ongi gi itu tu tudi din na nal ax xis from m m the e e a ap apic ic cal al l 4 4-c -ch ha hamb mb mber r v vie ie ew w. w. T The he he p pe ea ak k k ea earl r r y y y di dias as asto to oli li lic c ve ve elo lo loci city ty y ( ( (e' e') ) of of f t the h l l lat ater er eral al al a a and nd d t the he he s s sep p pt t tal al m m mit i r ra ral l an an annu nu nulu lu lus s we we were re r me me meas asu ur ured ed e a a and nd nd th h he a a ave ver ra rag ge ge value was ca alc lc cul ul u at at ted ed ed. . Di Di D as sto to toli li lic dy dy dysf sf fun un u c c cti ti t on on on d d def ef efin in nit it tio io on n wa wa was s s pu pu publ bl blis is ishe e ed d d pr pr prev ev evio io ious us sly ly ly. . . rate 45 fps, and were averaged for strain analysis. Aortic valve opening and closing times were measured from the LV outflow Doppler profile and were incorporated in the speckle-tracking strain profile in order to exclude post-systolic components. Because GLS is represented by negative values, with more negative numbers expressing greater systolic shortening and therefore better function, we adopted the terminology "lower GLS" referring to higher, less negative values, therefore expressing smaller systolic shortening. Abnormal GLS was defined as a GLS lower than the 95 th percentile of the GLS distribution in the healthy subgroup of subjects free of hypertension, diabetes mellitus, coronary artery disease, arrhythmias, and with body mass index 25 kg/m 2 , corresponding to a GLS > -14%. Reproducibility of speckle-tracking measurements has been reported previously.
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Brain Magnetic Resonance Imaging
A detailed description of the assessment of subclinical cerebrovascular lesions has been published previously. pub bl blis i hed prev vio io ious s sly y. . 9, 9 9 30 30 0 B B Bri ri rief ef efly ly, br br brai a n n n i imag g gin n ng wa wa was s pe pe er rf rfor orme med d on on n a a 1 1 1.5 . .
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Statistical analysis
Data are presented as means ± standard deviation (SD) for continuous variables and as percentages for categorical variables. Student's t-test was used to assess differences in GLS, LVEF, and WMHV between groups (presence/absence of SBI; normal/abnormal GLS and LVEF). Logistic and linear regression models were used to test the association of demographic and clinical variables with parameters of LV function, and the association of LV function parameters with SBI and log-WMVH. Unstandardized (B) and standardized ( ) parameter estimates, standard errors (SE), Pearson's partial correlation coefficients, odds ratios (OR) and 95% confidence intervals (CI) were calculated and reported. Covariates for multivariate models were selected based on their univariate association with LV function parameters, with a threshold for entry in the multivariate models set at a p-value less than 0.2. For all statistical analyses, a two-tailed p<0.05 was considered significant. Statistical analyses were performed using SAS software version 9.2 (SAS Institute Inc., Cary, NC).
Results
Study population
Clinical and demographic characteristics of the study population are shown in Table 1 . We detected SBI in 53 study participants (12%); in 9 cases (17%), the SBI were located in cortical areas and 44 (83%) were subcortical. Mean WMHV was 0.63±0.86% (median=0.32%, interquartile range=0.47%). Echocardiographic data, including LVEF and GLS of the study population are shown in Table 2 .
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Discussion
In this study, we demonstrated for the first time that GLS is associated with subclinical brain disease in a community-based cohort free of stroke and of overt cardiac disease. This association was significant for both SBI and WMHV, and was independent of confounders, cardiovascular risk factors, and of LVEF.
The mechanism underlying the association between a lower GLS and subclinical brain disease is not known. It is important to note that the vast majority (93.4%) of the study participants had a normal LVEF, making cerebral hypoperfusion, one of the proposed etiologic mechanisms for white matter lesions, 31, 32 an unlikely contributor to our findings. In this respect, we confirm the findings of the Framingham Heart Study, which showed no association between LVEF and WMHV in a large sample of subjects free from clinical stroke and with largely normal LVEF. 21 GLS, however, is an indicator of myocardial deformation that has a different meaning and behaves differently from LVEF, especially in the early subclinical stages of LV Discussion n n t t thi hi his s s st st stud ud udy, y y we e d de dem monstrated for the first time th th tha at t GLS is associ ci ciated d d w w wit i h subclinical brain d di dise e eas a e in a com ommu muni ni it ty t -b -b -bas as ased ed ed c coh oh hor or ort t f f fre e ee of f f s strok ke ke and d d o of f ov ov over ert t ca a ard rdia ia iac di dise se ea as ase. e. Th Th This is ass ss ssoc ocia ia iat ti t on wa wa as s s si si sign gn gnif ific ic ica an ant t f fo for r r bo both th S SBI BI a a and nd nd W W WMH MH MHV, V, V a a and nd nd w w wa a as i ind nd dep ep pen en ende de ent nt n o of f f c c con on onfo foun und de ders rs rs, , , ca ca car rd rdio o ova a asc scu u ula ar r f f f but not LVEF, was reduced in subjects with increased arterial stiffness. 37 The association of GLS with the aforementioned risk factors and with increased arterial stiffness, in otherwise asymptomatic subjects, may suggest GLS as an indicator of subclinical atherosclerosis.
Consistent with this hypothesis, a study in asymptomatic diabetic patients with normal LVEF
showed that a reduced GLS was associated with higher coronary artery calcium score, a direct marker of coronary atherosclerosis. 38 This association might therefore provide a pathophysiological explanation for the association between GLS and subclinical brain disease shown in the present study. Indeed, several studies showed that SBI and WMHV are associated with atherosclerotic and cardiovascular risk factors, such as hypertension, LV hypertrophy, diabetes, cigarette smoking, hyperhomocysteinemia, carotid plaque, and intima-media thickness. 2, 6, 9, 39, 40 The fact that the association between GLS and subclinical brain disease persisted after adjusting for many known risk factors for atherosclerotic disease may be compatible with the concept that, once atherosclerosis has developed, adjusting for these factors may no longer affect the risk estimates, or not as much. Furthermore, it is also possible that other unmeasured factors may be involved in mediating the observed associations.
While in patients with overt heart failure the presence of SBI has been hypothesized to be in part of thromboembolic origin 18 (because of the low cardiac output favoring blood stasis in the Consistent with this hypothesis, a study in asymptomatic diabetic patients with n no o orma ma m l l LV LV LVEF EF EF howed that a reduced GLS was associated with higher coronary artery calcium score, a direct ma mark rk rker er er o of f f co co c r r rona na ary ry ry atherosclerosis. 38 This assoc c ci ia i t ti ion might there re efore re e p p pr rovide a path h hop o hysiolog ogic ic ica al l e exp x xpla la ana na nati ti ion on on f for or or t t the he e a a assoc c cia a ation n n b b betwe we ween en n G G GLS LS S a a and nd s sub ub ubcl clin in inic ic ical al b b bra a ain in dis is isea ea ase se e h how ow own n n in in t the he he p pre rese e ent nt s s stu tu udy dy. In In Inde de deed ed ed, , se seve ve vera ra ral l l s stud ud udi ie e es s sho o owe we wed d d th h hat at a S S SBI BI BI a an n nd W WMH MH MHV V ar ar are e a as asso so oci cia a ate ed ed with atheroscl cl ler er erot ot tic ic ic a and nd nd car ar ardi di diov v vas as ascu cu ula lar r r ri ri isk sk sk f f fac ac acto to ors rs s, su su s ch ch ch a a as s s hy hy hype pe pert ten en ensi si sion on on, , LV LV L h h hyp yp yper er ertr tr t ophy, cardiac chambers), in the present study population this does not appear to be a likely cause, given the largely normal LVEF, the exclusion of participants with history of CAD, and the absence of LV thrombus in all study participants. Cardioembolism from paroxysmal atrial arrhythmias can theoretically be another mechanism for SBI occurrence. Although we excluded participants with history and ECG evidence of atrial arrhythmias, the presence of undocumented episodes of paroxysmal atrial fibrillation that may have contributed to our findings in participants with lower GLS cannot be excluded. It is known that patients with isolated paroxysmal atrial fibrillation but normal LVEF may have lower GLS compared to healthy controls, and that catheter ablation of the atrial fibrillation restores GLS to normal levels. 41 Additionally, we have previously demonstrated that a lower GLS is associated with reduced left atrial reservoir function, 28 which in turn is associated with the development of both atrial arrhythmias and subclinical brain disease. 42, 43 Although cardioembolism may be a theoretically possible link between lower GLS and SBI, it is unlikely that it played a significant role in explaining our findings. In fact, the number of cortical brain infarcts, generally considered of more likely embolic origin, in our study population was very low.
Our study has potential clinical implications. For the first time, we show that an echocardiographic parameter of LV systolic function can provide useful information about the risk of subclinical brain disease. We found that an abnormal GLS was associated with an over three-fold increase in risk of having a SBI in multivariate analysis, and, importantly, this association was independent of LVEF. The negative prognostic value of a reduced LVEF has been well documented in patients with heart failure, dilated cardiomyopathy, and in patients surviving myocardial infarctions. 16, 44, 45 It is also known that lower LVEF is associated with subclinical brain disease in the context of heart failure; 18, 19 however, probably because of our demonstrated that a lower GLS is associated with reduced left atrial reservoir fun un nct tio io i n n, n, 28 28 28 w w whi hi hich ch n turn is associated with the development of both atrial arrhythmia f s and subclinical brain di ise se eas as ase e. e. 42, 42, 42, 43 43 43 A A Alt tho ho hou ug ugh cardioembolism may be a a a th the eoretically poss ss s ibl le e li li lin nk between lower GLS an nd d d SB S I, it is u unl nl nlik k kel ly y th h hat at at i i it t pl pl play ayed ed ed a a s sig g gnifi fi ica a ant r r ro ol le in in n e exp xp pla la ain ini in ing g g ou our r r f fi ind nd din in ings gs. In In In f f fac ac ct, t t th he he nu numb mb mber er e o of f co co cort rtic ical al b bra ra ain n n i inf n ar ar rcts ts ts, ge ge gene nera ra rall ll lly y y co co c ns ns n id id 
Strengths and limitations
The main strengths of our study are the large number of subjects studied with advanced imaging techniques (speckle-tracking echocardiography and brain MRI), the wide range of cardiovascular risk profiles present in our study population, and the confirmation of our findings in multivariable models. However, our study also has limitations. The study sample included subjects over age 55 with a large representation of Hispanic ethnicity, which might preclude the generalization of our findings to populations with different demographic composition. However, since silent brain disease is more commonly found in the elderly, our study cohort was the ideal setting for this study. Furthermore, the cross-sectional design of our study allows us to document associations that do not necessarily imply direct cause-effect relationships. Finally, although we performed multivariate analyses adjusted for many known risk factors for atherosclerosis and brain disease, the possibility that unmeasured confounders might be involved in the observed clinical stroke and cognitive decline in those individuals is a hypothesis that des ser e erve ve es fu fu furt rt rthe he her r r nvestigation.
St tre re eng ng ngth th ths s s an an and li li im mi mita t tions
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Conclusions
A lower GLS was independently associated with subclinical brain lesions, both SBI and WMHV, in a stroke-free community-based cohort without overt cardiac disease. The traditional assessment of LV systolic function by LVEF was not associated with either SBI or WMHV.
GLS can provide additional information on cerebrovascular risk even when LVEF is in the normal range. The early identification of subjects at higher risk for subclinical brain disease may be crucial for intervention aiming at reducing the global burden of clinical stroke and cognitive decline. by guest on April 16, 2017 
